Severe Asthma Clinical Trial Pipeline Appears Robust With 40+ Key Pharma Companies Actively Working In The Therapeutics Segment Delveinsight
In May 2024, GSK announced positive headline results from the phase III clinical trials SWIFT-1 and SWIFT-2, which assessed the efficacy and safety of depemokimab versus placebo in adults and ...
Healthcare Asia on MSN40m
Here's why severe asthma market is growing
The severe asthma market is growing due to a rising number of cases, particularly in urban areas and advancements in treatment, according to DelveInsight's report. New biologic drugs targeting IgE and ...